Perceptive Advisors - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 65 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$192,000
-23.2%
14,6730.0%0.01%
-12.5%
Q3 2016$250,000
-21.9%
14,673
-2.2%
0.02%
-27.3%
Q2 2016$320,00015,0000.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders